Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1555605

This article is part of the Research Topic Herbal Medicine for the Treatment of Chronic Metabolic Diseases, Volume II View all 16 articles

Cardiorenal Protective Effects of Tanhuo Decoction in Acute Myocardial Infarction via Regulating Multi-target Inflammation and Metabolic Signaling Pathways

Provisionally accepted
Chenglong Guo Chenglong Guo 1Tianxing Zhang Tianxing Zhang 1Lingqian He Lingqian He 2Yanyan Chu Yanyan Chu 1Xipeng Sun Xipeng Sun 1Minyu Zhang Minyu Zhang 3Xuexue Han Xuexue Han 1Yijiang Liu Yijiang Liu 4*Juexian Song Juexian Song 2*Jinggang Xia Jinggang Xia 1*
  • 1 Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
  • 2 Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
  • 3 School of Traditional Chinese Medicine, Capital Medical University, Beijing, Beijing Municipality, China
  • 4 Senior Department of Hepatology, Fifth Medical Center of the PLA General Hospital, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

    Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide, with inflammation recognized as a major contributor to its adverse outcomes. Despite advances in Western medicine, the single-target focus and significant side effects of conventional anti-inflammatory therapies limit their effectiveness in addressing residual inflammatory risk. Traditional Chinese medicine (TCM), with its multi-target and low-toxicity profile, has emerged as a promising alternative. This study investigated the therapeutic effects of Tanhuo Decoction (THD) in combination with standard Western medicine (WM) in a randomized controlled trial involving AMI patients with high inflammatory responses. Over three days of treatment, the THD+WM group demonstrated significant reductions in neutrophil counts, hs-CRP levels, as well as an improvement in creatinine clearance rate (CCR), compared to the WM group. Proteomic and network pharmacology analyses revealed that THD regulates key inflammatory pathways, downregulating pro-inflammatory proteins such as PTX3, IL-18, and TNFRSF11A, while upregulating the anti-inflammatory IL1RL2. Furthermore, THD modulated metabolic pathways related to lipid metabolism and insulin sensitivity, underscoring its potential to address comorbid conditions such as diabetes and obesity. These findings highlight the cardiorenal protection of THD through multi-target regulation of inflammation and metabolic signaling pathways, providing robust evidence for its integration into modern cardiovascular care.

    Keywords: acute myocardial infarction, Tanhuo decoction, cardiorenal protection, Inflammation, Metabolism

    Received: 05 Jan 2025; Accepted: 12 Mar 2025.

    Copyright: © 2025 Guo, Zhang, He, Chu, Sun, Zhang, Han, Liu, Song and Xia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yijiang Liu, Senior Department of Hepatology, Fifth Medical Center of the PLA General Hospital, Beijing, 100049, Beijing Municipality, China
    Juexian Song, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, Beijing Municipality, China
    Jinggang Xia, Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, Beijing Municipality, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more